Synthetic antimicrobial related to NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.
COUMARINS with an amino group, exemplified by NOVOBIOCIN.
A vitamin antagonist which has teratogenic effects.
Quinolizines are heterocyclic organic compounds containing a bicyclic structure formed by a benzene ring fused to a piperidine ring, which have been used as building blocks in the synthesis of various pharmaceuticals and bioactive molecules.
Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189)
A persistent skin infection marked by the presence of furuncles, often chronic and recurrent. In humans, the causative agent is various species of STAPHYLOCOCCUS. In salmonid fish (SALMONIDS), the pathogen is AEROMONAS SALMONICIDA.
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.
Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid.
Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed).
DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
QUINOLONES containing a 4-oxo (a carbonyl in the para position to the nitrogen). They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.
Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates).
Substances that reduce the growth or reproduction of BACTERIA.
Quinolines are heterocyclic aromatic organic compounds consisting of a two-nitrogened benzene ring fused to a pyridine ring, which have been synthesized and used as building blocks for various medicinal drugs, particularly antibiotics and antimalarials.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

Efficacy of orally administered oxolinic acid and Vetoquinol, an oxolinic acid ester, for the treatment of furunculosis in Atlantic salmon Salmo salar held in seawater. (1/72)

This study was performed to determine the efficacy of orally administered oxolinic acid and Vetoquinol, an oxolinic acid ester, in the treatment of experimental induced furunculosis in Atlantic salmon Salmo salar held in seawater. Two strains of the causative bacterium Aeromonas salmonicida subsp. salmonicida, 1 sensitive (VI-88/09/03175) and 1 resistant (3475/90) to oxolinic acid, were used. In 2 trials, cohabitational challenges were performed by introducing 8 fish challenged in advance by an intraperitoneal injection of 2.2 x 10(4) colony forming units of strain 3475/90 (Trial 1) or strain VI-88/09/03175 (Trial 2) to 10 aquaria each containing 40 healthy fish. The treatment groups in both trials consisted of 4 groups receiving either oxolinic acid (2 groups) or Vetoquinol (2 groups) and 1 control group. An unchallenged, unmedicated group was used to determine the natural mortality in the population. The recommended therapeutic dose of 25 mg oxolinic acid kg-1 fish at Days 1, 2, 4, 6, 8 and 10 following initiation of treatment was used. Oral medication initiated at Day 10 (Trial 1) or Day 11 (Trial 2) following challenge significantly (p < 0.05) lowered the specific mortality in all drug-treated groups compared to the untreated control groups. Mortality in Vetoquinol-treated groups was significantly (p < 0.05) lower than in oxolinic acid-treated groups in Trial 1 whereas no significant (p < 0.05) difference in survival rate was found between the medicated groups in Trial 2.  (+info)

Antibacterial effect of chloramphenicol, thiamphenicol and florfenicol against aquatic animal bacteria. (2/72)

The minimum inhibitory concentration (MIC) was measured to evaluate the antibacterial activities of chloramphenicol (CP), thiamphenicol (TP) and florfenicol (FFC) against the aquatic bacterial isolates from soft-shell turtles, fish and shellfish. Amoxicillin (AMPC), oxytetracycline (OTC) and oxolinic acid (OA) were included to compare with above protein synthesis inhibitors. The results showed that the order of MIC range of the isolates from soft-shell turtles for tested drugs was OA>FFC, CP>TP> AMPC, OTC. The percentage of the resistant strains indicated that OA was the lowest (7.14%) and OTC was the highest (85.07%). The order of antibacterial activity against the isolates from fish was OA>FFC>CP>AMPC>OTC>TP. The percentage of the resistant strains revealed that OA (13.64%) and OTC (80.91%) were the lowest and the highest, respectively. For the isolates from shellfish, the order of antimicrobial activity was OA>CP, FFC>AMPC, OTC, TP. TP showed the greatest percentage of the resistant strains (58.7%), but that of OA was the lowest (4.35%). The most common resistant patterns of the isolates from turtles, fish and shellfish were AMPC-OTC, CP-TP-AMPC-OTC, and FFC-CP-TP-AMPC-OTC, respectively. There were partially-complete resistance of the resistant isolates among CP, TP and FFC. The findings indicated that previous treatment might affect the choice of drug to use for aquatic bacterial diseases.  (+info)

A cosolvency model to predict solubility of drugs at several temperatures from a limited number of solubility measurements. (3/72)

A cosolvency model to predict the solubility of drugs at several temperatures was derived from the excess free energy model of Williams and Amidon. The solubility of oxolinic acid, an antibacterial drug, was measured in aqueous (water+ethanol) and non-aqueous (ethanol+ethyl acetate) mixtures at several temperatures (20, 30, 35, 40 degrees C). Oxolinic acid displays a solubility maximum in each solvent mixture at solubility parameter values of 32 and 22 MPa(1/2). The temperature and heat of fusion were determined from differential scanning calorimetry. The solvent mixtures do not produce any solid phase change during the solubility experiments. The experimental results and those from the literature were employed to examine the accuracy and prediction capability of the proposed model. An equation was obtained to represent the drug solubility changes with cosolvent concentration and temperature. The model was also tested using a small number of experimental solubilities at 20 and 40 degrees C showing reasonably accurate predictions. This is important in pharmaceutics because it save experiments that are often expensive and time consuming.  (+info)

Oxolinic acid in the treatment of typhoid fever due to chloramphenicol-resistant strains of Salmonella typhi. (4/72)

Of 28 strains of Salmonella typhosa collected in late 1972 in Vietnam, 4 had minimum inhibitory concentrations to chloramphenicol of >100 mug/ml. Median minimum inhibitory concentrations of all strains to oxolinic acid were 0.39 mug/ml; ampicillin, 6.25 mug/ml; amoxicillin, 0.39 mug/ml. Widespread typhoid fever appeared in mid-1973 with more than three-fourths of strains found to be resistant to chloramphenicol. Peak serum concentrations of oxolinic acid average 3.0 mug/ml after the oral ingestion of 1.0 g. In July 1974, a pilot study was begun to evaluate the efficacy of oxolinic acid in vivo, recognizing the discrepancy between in vitro and in vivo results with many agents evaluated in the treatment of typhoid fever. Seven patients with typhoid fever, six with positive blood cultures, were treated with oxolinic acid (1.5 g twice daily by mouth, a daily dose that averaged 75 mg/kg per day) for 5 to 12 days. In four of six patients, blood cultures became negative at 2 to 3 days, with another being negative at 6 days. Despite negative blood cultures, all but one patient remained clinically ill with temperatures of >39.5 C at 4 to 9 days. All strains were susceptible to 0.19 mug of oxolinic acid per ml, and resistant strains did not occur. One patient died after being changed to ampicillin, one left against advice, three responded to amoxicillin, and one died with pseudomonas bacteremia. Toxicity to oxolinic acid did not occur.  (+info)

In vitro susceptibility comparisons and recommendations for oxolinic acid. (5/72)

Minimal inhibitory concentration and disk diffusion susceptibility studies were carried out with oxolinic acid to determine a recommended disk content for disk susceptibility testing. Regression curve analyses were performed with disks containing 1, 2, and 5 mug of oxolinic acid. Data suggest that the 5-mug disk more satisfactorily fulfills requirements for susceptibility testing than the 1- or 2-mug disks evaluated. Ultraviolet spectral analysis studies for absorption maxima and extinction coefficients were done to verify the authenticity and concentration of oxolinic acid in the aqueous solutions studied.  (+info)

Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid. (6/72)

Cinoxacin and nalidixic acid were found to be similar in in vitro activity against 138 Shigella isolates and somewhat less active than oxolinic acid on a weight basis. Cross-resistance developed when 10 shigellae were transferred on increasing amounts of the respective agent contained in Mueller-Hinton agar. Plate dilution studies of the effect of changes in agar pH on the minimum inhibitory concentration revealed that the antibacterial activity increased with decreasing pH. Protein binding investigations revealed a high degree of binding, with nalidixic acid > oxolinic acid > cinoxacin.  (+info)

Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones. (7/72)

Antimicrobial susceptibility of seven clinical strains of Yersinia ruckeri representative of those isolated between 1994 and 2002 from a fish farm with endemic enteric redmouth disease was studied. All isolates displayed indistinguishable pulsed-field gel electrophoresis restriction patterns, indicating that they represented a single strain. However, considering both inhibition zone diameters (IZD) and MICs, the isolates recovered in 2001-2002 formed a separate cluster with lower levels of susceptibility to all the quinolones tested, especially nalidixic acid (NA) and oxolinic acid (OA), compared with the isolates recovered between 1994 and 1998. Analysis of the PCR product of the quinolone resistance-determining region of the gyrA gene from clinical isolates of Y. ruckeri with reduced susceptibility to OA and NA revealed a single amino acid substitution, Ser-83 to Arg-83 (Escherichia coli numbering). Identical substitution was observed in induced OA-resistant mutant strains, which displayed IZD and MICs of quinolones similar to those of the clinical isolates of Y. ruckeri with reduced susceptibility to these antimicrobial agents. These data indicate in that for Y. ruckeri, the substitution of Ser by Arg at position 83 of the gyrA gene is associated with reduced susceptibility to quinolones.  (+info)

Relationship between gyrA mutations and quinolone resistance in Flavobacterium psychrophilum isolates. (8/72)

Flavobacterium psychrophilum is the causative agent of the fish diseases called bacterial cold-water disease and rainbow trout fry syndrome. It has been reported that some isolates of F. psychrophilum are resistant to quinolones; however, the mechanism of this quinolone resistance has been unexplained. In this study, we examined the quinolone susceptibility patterns of 27 F. psychrophilum strains isolated in Japan and the United States. Out of 27 isolates, 14 were resistant to both nalidixic acid (NA) and oxolinic acid (OXA), and the others were susceptible to NA and OXA. When amino acid sequences deduced from gyrA nucleotide sequences of all isolates tested were analyzed, two amino acid substitutions (a threonine residue replaced by an alanine or isoleucine residue in position 83 of GyrA [Escherichia coli numbering] and an aspartic acid residue replaced by a tyrosine residue in position 87) were observed in the 14 quinolone-resistant isolates. These results strongly suggest that, as in other gram-negative bacteria, DNA gyrase is an important target for quinolones in F. psychrophilum.  (+info)

Oxolinic acid is an antimicrobial agent primarily used in the treatment of bacterial infections, particularly those caused by Gram-negative bacteria. It functions as a quinolone antibiotic and works by inhibiting the DNA gyrase enzyme in bacteria, thereby preventing DNA replication and transcription.

Oxolinic acid is available in various forms, such as ointments, creams, and eye drops, and is commonly used to treat conditions like conjunctivitis (pink eye) and other superficial bacterial infections of the skin and eyes. It may also be used for other purposes not mentioned in this definition.

It's important to note that oxolinic acid has limited systemic absorption, which means it is not typically used to treat systemic infections. Additionally, as with any medication, it should only be used under the guidance and supervision of a healthcare professional, as misuse or overuse can lead to antibiotic resistance.

Nalidixic acid is an antimicrobial agent, specifically a synthetic quinolone derivative. It is primarily used for the treatment of urinary tract infections caused by susceptible strains of gram-negative bacteria, such as Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.

Nalidixic acid works by inhibiting bacterial DNA gyrase, an enzyme necessary for DNA replication. This leads to the prevention of DNA synthesis and ultimately results in bacterial cell death. However, its use has become limited due to the emergence of resistance and the availability of more effective antimicrobials.

It is essential to note that nalidixic acid is not typically used as a first-line treatment for urinary tract infections or any other type of infection. It should only be used when other antibiotics are not suitable due to resistance, allergies, or other factors. Additionally, the drug's potential side effects, such as gastrointestinal disturbances, headaches, and dizziness, may limit its use in some patients.

Aminocoumarins are a class of antibiotics that inhibit bacterial DNA gyrase, an enzyme necessary for DNA replication and transcription. These antibiotics have a coumarin nucleus with an attached amino group. The most well-known aminocoumarin is novobiocin, which is used to treat various bacterial infections. However, the use of aminocoumarins has become limited due to the emergence of bacterial resistance and the availability of other more effective antibiotics.

6-Aminonicotinamide is a pharmacological compound that is an analog of nicotinamide, which is the amide form of vitamin B3 (niacin). Chemically, 6-Aminonicotinamide has a structure similar to nicotinamide, but with an amino group (-NH2) replacing a hydrogen atom at the 6th position of the pyridine ring.

This compound has been used in research to study the biochemical pathways related to nicotinamide and its role in cellular metabolism. It is known to inhibit the activity of certain enzymes, including nicotinamide phosphoribosyltransferase (NAMPT), which plays a crucial role in the biosynthesis of NAD+, an essential coenzyme involved in various redox reactions and energy metabolism in cells.

Due to its inhibitory effects on NAMPT, 6-Aminonicotinamide has been investigated as a potential therapeutic agent for cancer treatment, as disrupting NAD+ biosynthesis may selectively target and kill cancer cells with high metabolic demands. However, the use of 6-Aminonicotinamide in clinical settings is not yet established, and further research is needed to determine its safety and efficacy.

Quinolizines are not a medical term, but a chemical classification for a group of compounds that contain a quinolizine ring in their structure. A quinolizine ring is a polycyclic aromatic hydrocarbon with eight pi electrons and consists of two benzene rings fused to a piperidine ring.

Quinolizines have been studied for their potential medicinal properties, including anti-malarial, anti-cancer, and anti-microbial activities. However, there are no currently approved drugs that contain quinolizine as the primary active ingredient. Therefore, it is not possible to provide a medical definition of 'Quinolizines.'

Cinoxacin is a fluoroquinolone antibiotic that is used to treat bacterial infections of the urinary tract. It works by inhibiting the DNA gyrase enzyme, which is necessary for the bacteria to replicate and repair themselves. This leads to the death of the bacteria and the resolution of the infection.

Cinoxacin is available as a prescription medication and is typically taken by mouth in the form of a tablet or capsule. It is important to take cinoxacin exactly as directed by your healthcare provider, and to complete the full course of treatment even if you start feeling better before all of the medication has been taken.

Like all antibiotics, cinoxacin can cause side effects, including nausea, vomiting, diarrhea, and headache. It may also cause more serious side effects, such as tendonitis, nerve damage, and changes in mood or behavior. If you experience any of these side effects, it is important to contact your healthcare provider right away.

Cinoxacin should not be used in people who are allergic to fluoroquinolone antibiotics, or in children under the age of 18. It should also be used with caution in people who have a history of kidney or liver disease, seizures, or nerve disorders. Before taking cinoxacin, it is important to tell your healthcare provider about all of the medications you are taking, as well as any medical conditions you have.

Novobiocin is an antibiotic derived from the actinomycete species Streptomyces niveus. It belongs to the class of drugs known as aminocoumarins, which function by inhibiting bacterial DNA gyrase, thereby preventing DNA replication and transcription. Novobiocin has activity against a narrow range of gram-positive bacteria, including some strains of Staphylococcus aureus (particularly those resistant to penicillin and methicillin), Streptococcus pneumoniae, and certain mycobacteria. It is used primarily in the treatment of serious staphylococcal infections and is administered orally or intravenously.

It's important to note that Novobiocin has been largely replaced by other antibiotics due to its narrow spectrum of activity, potential for drug interactions, and adverse effects. It is not widely used in clinical practice today.

Furunculosis is a skin condition characterized by the recurrent development of boils or furuncles. A furuncle is a deep infection of the hair follicle and surrounding tissue, typically caused by the bacterium Staphylococcus aureus. These infections can be painful, red, swollen, and may contain pus.

Furunculosis occurs when a person has recurring furuncles, often due to persistent or frequent reinfection with S. aureus. This condition is more common in people with weakened immune systems, diabetes, poor hygiene, or who have close contact with someone infected with S. aureus.

Treatment for furunculosis usually involves antibiotics, either topical or oral, to eliminate the infection-causing bacteria. In some cases, incision and drainage of the boil may be necessary. Maintaining good hygiene, keeping the affected area clean, and avoiding sharing personal items like towels or razors can help prevent the spread and recurrence of furuncles.

Topoisomerase II inhibitors are a class of anticancer drugs that work by interfering with the enzyme topoisomerase II, which is essential for DNA replication and transcription. These inhibitors bind to the enzyme-DNA complex, preventing the relaxation of supercoiled DNA and causing DNA strand breaks. This results in the accumulation of double-stranded DNA breaks, which can lead to apoptosis (programmed cell death) in rapidly dividing cells, such as cancer cells. Examples of topoisomerase II inhibitors include etoposide, doxorubicin, and mitoxantrone.

Coumarins are a class of organic compounds that occur naturally in certain plants, such as sweet clover and tonka beans. They have a characteristic aroma and are often used as fragrances in perfumes and flavorings in food products. In addition to their use in consumer goods, coumarins also have important medical applications.

One of the most well-known coumarins is warfarin, which is a commonly prescribed anticoagulant medication used to prevent blood clots from forming or growing larger. Warfarin works by inhibiting the activity of vitamin K-dependent clotting factors in the liver, which helps to prolong the time it takes for blood to clot.

Other medical uses of coumarins include their use as anti-inflammatory agents and antimicrobial agents. Some coumarins have also been shown to have potential cancer-fighting properties, although more research is needed in this area.

It's important to note that while coumarins have many medical uses, they can also be toxic in high doses. Therefore, it's essential to use them only under the guidance of a healthcare professional.

I'm sorry for any confusion, but "Salmon" is not a medical term. It is a common name for various species of fish that belong to the family Salmonidae and are known for their distinctive pink or red flesh. They are an important source of food and are popular in many cuisines around the world. If you have any questions about medical terminology, I'd be happy to help with those instead!

DNA topoisomerases are enzymes that regulate the topological state of DNA during various cellular processes such as replication, transcription, and repair. They do this by introducing temporary breaks in the DNA strands and allowing the strands to rotate around each other, thereby relieving torsional stress and supercoiling. Topoisomerases are classified into two types: type I and type II.

Type II topoisomerases are further divided into two subtypes: type IIA and type IIB. These enzymes function by forming a covalent bond with the DNA strands, cleaving them, and then passing another segment of DNA through the break before resealing the original strands. This process allows for the removal of both positive and negative supercoils from DNA as well as the separation of interlinked circular DNA molecules (catenanes) or knotted DNA structures.

Type II topoisomerases are essential for cell viability, and their dysfunction has been linked to various human diseases, including cancer and neurodegenerative disorders. They have also emerged as important targets for the development of anticancer drugs that inhibit their activity and induce DNA damage leading to cell death. Examples of type II topoisomerase inhibitors include etoposide, doxorubicin, and mitoxantrone.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

4-Quinolones are a class of antibacterial agents that are chemically characterized by a 4-oxo-1,4-dihydroquinoline ring. They include drugs such as ciprofloxacin, levofloxacin, and moxifloxacin, among others. These antibiotics work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, repair, and recombination. This leads to bacterial cell death.

4-Quinolones have a broad spectrum of activity against both Gram-positive and Gram-negative bacteria and are used to treat a variety of infections, including urinary tract infections, pneumonia, skin and soft tissue infections, and intra-abdominal infections. However, the use of 4-quinolones is associated with an increased risk of tendinitis and tendon rupture, as well as other serious adverse effects such as peripheral neuropathy, QT interval prolongation, and aortic aneurysm and dissection. Therefore, their use should be restricted to situations where the benefits outweigh the risks.

'Aeromonas' is a genus of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are widely distributed in aquatic environments. Some species of Aeromonas can cause various types of infections in humans, including gastrointestinal illnesses, wound infections, and septicemia. These bacteria are often associated with water exposure or contaminated food, and they can infect individuals with weakened immune systems.

The most common species that cause human infections are Aeromonas hydrophila, Aeromonas caviae, and Aeromonas veronii. Symptoms of infection may include diarrhea, abdominal pain, nausea, vomiting, fever, and skin or soft tissue infections. In severe cases, Aeromonas infections can lead to sepsis, meningitis, or endocarditis.

It's important to note that while Aeromonas infections can be serious, they are relatively rare and typically only affect individuals with compromised immune systems. Proper hygiene practices, such as handwashing and avoiding contaminated food and water, can help prevent the spread of these bacteria.

Superhelical DNA refers to a type of DNA structure that is formed when the double helix is twisted around itself. This occurs due to the presence of negative supercoiling, which results in an overtwisted state that can be described as having a greater number of helical turns than a relaxed circular DNA molecule.

Superhelical DNA is often found in bacterial and viral genomes, where it plays important roles in compacting the genome into a smaller volume and facilitating processes such as replication and transcription. The degree of supercoiling can affect the structure and function of DNA, with varying levels of supercoiling influencing the accessibility of specific regions of the genome to proteins and other regulatory factors.

Superhelical DNA is typically maintained in a stable state by topoisomerase enzymes, which introduce or remove twists in the double helix to regulate its supercoiling level. Changes in supercoiling can have significant consequences for cellular processes, as they can impact the expression of genes and the regulation of chromosome structure and function.

Fluoroquinolones are a class of antibiotics that are widely used to treat various types of bacterial infections. They work by interfering with the bacteria's ability to replicate its DNA, which ultimately leads to the death of the bacterial cells. Fluoroquinolones are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

Some common fluoroquinolones include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin. These antibiotics are often used to treat respiratory infections, urinary tract infections, skin infections, and gastrointestinal infections, among others.

While fluoroquinolones are generally well-tolerated, they can cause serious side effects in some people, including tendonitis, nerve damage, and changes in mood or behavior. As with all antibiotics, it's important to use fluoroquinolones only when necessary and under the guidance of a healthcare provider.

'Proteus' doesn't have a specific medical definition itself, but it is related to a syndrome in medicine. Proteus syndrome is a rare genetic disorder characterized by the overgrowth of various tissues and organs in the body. The name "Proteus" comes from the Greek god Proteus, who could change his form at will, reflecting the diverse and ever-changing nature of this condition's symptoms.

People with Proteus syndrome experience asymmetric overgrowth of bones, skin, and other tissues, leading to abnormalities in body shape and function. The disorder can also affect blood vessels, causing benign tumors called hamartomas to develop. Additionally, individuals with Proteus syndrome are at an increased risk of developing certain types of cancer.

The genetic mutation responsible for Proteus syndrome is found in the AKT1 gene, which plays a crucial role in cell growth and division. This disorder is typically not inherited but instead arises spontaneously as a new mutation in the affected individual. Early diagnosis and management of Proteus syndrome can help improve patients' quality of life and reduce complications associated with the condition.

"Fish diseases" is a broad term that refers to various health conditions and infections affecting fish populations in aquaculture, ornamental fish tanks, or wild aquatic environments. These diseases can be caused by bacteria, viruses, fungi, parasites, or environmental factors such as water quality, temperature, and stress.

Some common examples of fish diseases include:

1. Bacterial diseases: Examples include furunculosis (caused by Aeromonas salmonicida), columnaris disease (caused by Flavobacterium columnare), and enteric septicemia of catfish (caused by Edwardsiella ictaluri).

2. Viral diseases: Examples include infectious pancreatic necrosis virus (IPNV) in salmonids, viral hemorrhagic septicemia virus (VHSV), and koi herpesvirus (KHV).

3. Fungal diseases: Examples include saprolegniasis (caused by Saprolegnia spp.) and cotton wool disease (caused by Aphanomyces spp.).

4. Parasitic diseases: Examples include ichthyophthirius multifiliis (Ich), costia, trichodina, and various worm infestations such as anchor worms (Lernaea spp.) and tapeworms (Diphyllobothrium spp.).

5. Environmental diseases: These are caused by poor water quality, temperature stress, or other environmental factors that weaken the fish's immune system and make them more susceptible to infections. Examples include osmoregulatory disorders, ammonia toxicity, and low dissolved oxygen levels.

It is essential to diagnose and treat fish diseases promptly to prevent their spread among fish populations and maintain healthy aquatic ecosystems. Preventative measures such as proper sanitation, water quality management, biosecurity practices, and vaccination can help reduce the risk of fish diseases in both farmed and ornamental fish settings.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Quinolines are a class of organic compounds that consist of a bicyclic structure made up of a benzene ring fused to a piperidine ring. They have a wide range of applications, but they are perhaps best known for their use in the synthesis of various medications, including antibiotics and antimalarial drugs.

Quinolone antibiotics, such as ciprofloxacin and levofloxacin, work by inhibiting the bacterial enzymes involved in DNA replication and repair. They are commonly used to treat a variety of bacterial infections, including urinary tract infections, pneumonia, and skin infections.

Quinoline-based antimalarial drugs, such as chloroquine and hydroxychloroquine, work by inhibiting the parasite's ability to digest hemoglobin in the red blood cells. They are commonly used to prevent and treat malaria.

It is important to note that quinolines have been associated with serious side effects, including tendinitis and tendon rupture, nerve damage, and abnormal heart rhythms. As with any medication, it is important to use quinolines only under the supervision of a healthcare provider, and to follow their instructions carefully.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

... is a quinolone antibiotic developed in Japan in the 1970s. Dosages 12-20 mg/kg orally administered for five to ... oxolinic acid". American Journal of Hospital Pharmacy. 36 (8): 1077-9. PMID 384788. Garcia de Mateos-Verchere J, Vaugeois JM, ... Naudin B, Costentin J (December 1998). "Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a ... Amfonelic acid Fluoroquinolone JP Patent 49138244 Gleckman R, Alvarez S, Joubert DW, Matthews SJ (August 1979). "Drug therapy ...
Amfonelic acid Oxolinic acid Emmerson AM, Jones AM (May 2003). "The quinolones: decades of development and use". The Journal of ... nalidixic acid itself was used clinically, starting in 1967. Nalidixic acid is effective primarily against Gram-negative ... Nalidixic acid and related antibiotics inhibit a subunit of DNA gyrase and topoisomerase IV and induce formation of cleavage ... "Nalidixic acid spectrum of bacterial susceptibility and Resistance" (PDF). Toku-E. 2011-09-14. Archived from the original (PDF ...
Several quinolone antibiotic structures such as rosoxacin, oxolinic acid, droxacin, etc. Another example is in the synthesis of ... The ester group is hydrolysed by sodium hydroxide to the carboxylic acid and decarboxylation again by application of heat to 4- ... Saponification results in the formation of an acid. This step is followed by decarboxylation to give 4-hydroxyquinoline. The ... In this reaction aniline or an aniline derivative first reacts with malonic acid derivative ethyl ethoxymethylenemalonate with ...
A selective medium for G. vaginalis is colistin-oxolinic acid blood agar. G. vaginalis is a facultatively anaerobic Gram- ... Boric acid has been shown to be effective against BV, due to its ability to remove BV-specific biofilms and enhance eradication ... Finally, the nucleic acid amplification tests (NAATs), such as PCR, are commonly used detection techniques due to its ability ... FemExam cards and nucleic acid amplification tests (NAATs), resulting in the determination of an ongoing BV infection. The OSOM ...
Nalidixic acid (WIN 18,320) Oxolinic acid Pipemidic acid A-77636 Morris H (October 2015). "Sad Pink Monkey Blues". Harper's ... Amfonelic acid displays no activity in the norepinephrine system. Despite its different mechanism of action, amfonelic acid ... Amfonelic acid has been shown to be neuroprotective against methamphetamine damage to dopamine neurons. It also increases the ... Amfonelic acid (AFA; WIN 25,978) is a research chemical and dopaminergic stimulant with antibiotic properties. Although limited ...
The subunit A is selectively inactivated by antibiotics such as oxolinic and nalidixic acids. The subunit B is selectively ... Dar A, Prusty D, Mondal N, Dhar SK (November 2009). "A unique 45-amino-acid region in the toprim domain of Plasmodium ... The quinolones (including nalidixic acid and ciprofloxacin) are known as topoisomerase poisons. By binding to the enzyme they ... Bacterial DNA gyrase is the target of many antibiotics, including nalidixic acid, novobiocin, albicidin, and ciprofloxacin. The ...
April 27-28, 2005). Confirmation of Oxolinic Acid and Flumequine Residues in Shrimp by Liquid Chromatography with Tandem Mass ... Flumequine is a 9-fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid. The molecular formula is ... The first quinolone used was nalidixic acid (was marketed in many countries as Negram) followed by the fluoroquinolone ... "Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof - Patent 3896131". Freepatentsonline.com. Retrieved ...
... is similar chemically (and in antimicrobial activity) to oxolinic acid and nalidixic acid. Relative to nalidixic acid ... This first generation also included other quinolone drugs such as pipemidic acid, and oxolinic acid, but this first generation ... Synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections Oclassen ... synthetic antimicrobial related to the quinolone class of antibiotics with activity similar to oxolinic acid and nalidixic acid ...
The first generation also included other quinolone drugs, such as pipemidic acid, oxolinic acid, and cinoxacin, which were ... nalidixic acid, and piromidic acid, pipemidic acid The second-generation class is sometimes subdivided into "Class 1" and " ... flumequine (veterinary use) oxolinic acid rosoxacin Structurally related first-generation drugs, but formally not 4-quinolones ... but structurally distinct naphthyridine-family nalidixic acid in 1962 for treatment of UTIs in humans. Nalidixic acid was ...
... oxolinic acid (INN) oxomemazine (INN) oxonazine (INN) oxophenarsine (INN) oxoprostol (INN) oxpheneridine (INN) oxprenoate ... oxidronic acid (INN) oxifentorex (INN) oxifungin (INN) oxiglutatione (INN) Oxilan oxilofrine (INN) oxilorphan (INN) oximonam ( ... INN) oxindanac (INN) oxiniacic acid (INN) oxiperomide (INN) oxipurinol (INN) oxiracetam (INN) oxiramide (INN) oxisopred (INN) ...
Sarafloxacin J01MB01 Rosoxacin J01MB02 Nalidixic acid J01MB03 Piromidic acid J01MB04 Pipemidic acid J01MB05 Oxolinic acid ... J01XA03 Telavancin J01XA04 Dalbavancin J01XA05 Oritavancin J01XB01 Colistin J01XB02 Polymyxin B J01XC01 Fusidic acid J01XD01 ... J01XX01 Fosfomycin J01XX02 Xibornol J01XX03 Clofoctol J01XX04 Spectinomycin J01XX05 Methenamine J01XX06 Mandelic acid J01XX07 ...
... nalidixic acid MeSH D03.438.810.835.055.550 - nedocromil MeSH D03.438.810.835.055.580 - oxolinic acid MeSH D03.438.810.835.188 ... pipemidic acid MeSH D03.383.725.547.650 - piromidic acid MeSH D03.383.725.547.900 - 3-pyridinecarboxylic acid, 1,4-dihydro-2,6- ... niflumic acid MeSH D03.066.515.635 - pipemidic acid MeSH D03.066.515.650 - piromidic acid MeSH D03.066.515.950 - xanthinol ... lysergic acid MeSH D03.132.327.287.572.522 - lysergic acid diethylamide MeSH D03.132.327.287.630 - metergoline MeSH D03.132. ...
Oxolinic acid is a quinolone antibiotic developed in Japan in the 1970s. Dosages 12-20 mg/kg orally administered for five to ... oxolinic acid". American Journal of Hospital Pharmacy. 36 (8): 1077-9. PMID 384788. Garcia de Mateos-Verchere J, Vaugeois JM, ... Naudin B, Costentin J (December 1998). "Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a ... Amfonelic acid Fluoroquinolone JP Patent 49138244 Gleckman R, Alvarez S, Joubert DW, Matthews SJ (August 1979). "Drug therapy ...
Impaired function of PBGD leads to the accumulation of the porphyrin precursors porphobilinogen and amino-levulinic acid (ALA ...
Oxolinic acid 517 998 546 1035 977 1119 406 Total 645 1219 805 1159 1215 1478 649 ...
acetic acid [1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-hydroxy-3-methylbutan-2-yl] ester. 0. ... acetic acid [1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-hydroxy-3-methylbutan-2-yl] ester. 0. ... 1R,2R,3S,5R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid. 0. ... 1R,2R,3S,5R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid. 0. ...
Part 10: Quinolones: flumequine and oxolinic acid Konstantinos Koutsoumanis, Ana Allende, Avelino Alvarez-Ordóñez, Declan ... Substrate-bound outward-open structure of a Na+-coupled sialic acid symporter reveals a new Na+ site. ...
A mixed copper complex with deprotonated nalidixic acid (nal) and histamine (hsm) was synthesized and characterized by FTIR, UV ... examples of these drugs are Nalidixic acid, Oxolinic acid and Cinoxacin. The fluoroquinolones, second generation, like ... nalidixic acid, [. C. u. (. h. s. m. ). ]. 2. +. , hsm, and [Cu(hsm)(nal). H. 2. O. ]. C. l. ⋅. 3. H. 2. O. complex to a final ... K. Timmers and R. Sternglanz, "Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids," ...
Oxolinic acid. Reducing sugars content. Test Code. Analyte. Composite/No. of results. Units. Limit of reporting. ... Hydrocyanic acid. Permitted/. 1 result. mg/kg. 5. Inorganic arsenic. Note: report at 85% hydration in the test methods ... sum of trifloxystrobin and its acid metabolite ((E,E)-methoxyimino-[2-[1-(3-trifluoromethylphenyl)-ethylideneaminooxymethyl] ...
The first-generation formulation included cinoxacin, nalidixic acid and oxolinic acid. These early quinolones targeted gram- ... Nalidixic acid was once the most commonly used preparation, but poor tissue and serum concentrations now limit its use to the ...
Vis forfatter(e) (2019). Pharmacokinetic Data Show That Oxolinic Acid and Flumequine Are Absorbed and Excreted Rapidly From ...
Impaired function of PBGD leads to the accumulation of the porphyrin precursors porphobilinogen and amino-levulinic acid (ALA ...
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in ... Nalidixic acid, the first quinolone introduced into clinical practice, was developed in the 1960s; its use was largely confined ... Other quinolones have been available in the past (nalidixic acid, enoxacin, trovafloxacin, and gatifloxacin) but have been ...
... oxolinic acid, penicillin G, pipemidic acid, sulfamethoxazole, triclocarban, tetracycline, triflualin, and vancomycin. All ... Removal was not observed for atrazine, ciprofloxacin, erythromycin, oxolinic acid, tetracycline, and trifluralin. Pond water ...
Flumequine, Nalidixic Acid, Oxolinic Acid, Ciprofloxacin, Danofloxacin, Difloxacin, Enrofloxacin, Marbofloxacin, Norfloxacin, ...
In vitro sensitivity of some fish pathogens to the quinolones naladixic acid and oxolinic acid and the fluoroquinolone ...
... oxolinic acid, penicillin G, sulfamethoxazole, linezolid, pipemidic acid and vancomycin (Kulkarni et al. 2019). Evaluating the ... Nitric Acid (HNO3) (TraceMetal Grade) from Fisher Chemical was used. All solvents (chromatographic grade) and chemicals were ... formic acid. The extracts were dried under gentle nitrogen flow at 45 °C and reconstituted with 1 mL of a 90:10 Water: Methanol ...
Buy Cinnabarinic acid for research. Visit TOKU-E.com for details. ... Cinnabarinic acid induces apoptosis in T cells through ... Cinnabarinic acid is an endogenous kynurenine metabolite formed from oxidative dimerization of 3-​hydroxyanthranilic acid and ... Hariamatsu R et al (2008) Cinnabarinic acid generated from 3-​hydroxyanthranilic acid strongly induces apoptosis in thymocytes ... Cinnabarinic acid activates glutamate receptors by interacting with residues of the glutamate binding pocket of mGlu4. ...
Isolation of cyclopiazonic acid, cyclopiazonic acid imine and bissecodehydrocyclopiazonic acid from the cultures of Aspergillus ... Cyclopiazonic acid is soluble in ethanol, methanol, DMF and DMSO. Mechanism of Action. Cyclopiazonic acid is a highly specific ... Cyclopiazonic acid is a tremorigenic indole produced by several species of Aspergillus and Penicillium. Cyclopiazonic acid is a ... Cyclopiazonic acid and related toxins. Holzapfel C. W. In A. Ciegler, S. Kadis and S. J. Ajl (ed.) Microbial toxins, vol. VI. ...
d) DNA topoisomerase type II (gyrase) inhibitor: oxolinic acid. (2) Mitotic inhibitors and cell division inhibitors: (a) β- ... Myristic acid ester 10 parts Isopropanol balance Preparation Example 8 (Spot-on Agent) Active ingredient 10-15 parts Palmitic ... acid ester 10 parts Isopropanol balance Preparation Example 9 (Spray-on Agent) Active ingredient 1 part Propylene glycol 10 ... nordihydroguaiaretic acid or the like; preservatives such as dehydroacetic acid or the like; accidental ingestion preventive ...
Colistin-Oxolinic Acid-Blood Agar (COBA). The figure shows a COBA plate, on which Streptococcus equi subsp. zooepidemicus, that ... Colistin-Oxolinic Acid-Blood Agar (COBA) is a selective medium, which is used for isolation of streptococci. The medium ... and Klebsiella spp.) form colonies that seem to be red or pink, because acid is formed and the medium change colour when ... Lactose fermenting bacteria lower the pH of the medium to acid, which causes the medium to change in colour from blue-purple to ...
Part 10: Quinolones: flumequine and oxolinic acid EFSA Panel on Biological Hazards (BIOHAZ); Koutsoumanis, Konstantinos; ... The specific concentrations of flumequine and oxolinic acid in non-target feed for food-producing animals, below which there ... Impact of Diets Including Agro-Industrial By-Products on the Fatty Acid and Sterol Profiles of Larvae Biomass from Ephestia ...
1 oxolinic acid, 2 nalidixic acid, 3 flumequine, 4 norfloxacin, 5 ciprofloxacin, 6 da- ... acid, nalidixic acid and flumequine, and an excitation ... nalidixic acid y = 2.754e-4x - 0.1689 0.9999 3.78 98.9 ... oxolonic acid y = 1.408e-4x - 0.1116 0.9999 0.44 94.5 ... sion wavelength of 365 nm were selected for oxolinic ...
China biggest Manufacturer Factory Supply Oxolinic Acid Sodium CAS 13297-17-1 ... Orotic Acid Monohydrate -800MT/Year. Thiamine Hydrochloride -600MT/Year. Sodium Fusidate -15MT/Year. Fusidic Acid -200MT/Year. ... Ellagic Acid -150MT/Year. Pomegranate Peel Extract (Ellagic Acid) -150MT/Year. Cosmetics Ingredients. Cordycepin-1MT/Year. ... N-Acetylneuraminic Acid/SIALIC ACID-5MT/Year. Procysteine-10MT/Year. Potassium 4-salicylate-15MT/Year. Piroctone Olamine-10MT/ ...
Niflumic acid. Nitrous oxide. Norfloxacin. Ofloxacin. Oxolinic acid. Oxybuprocaine. [Oxyphenbutazone]. Oxytocin. [Pancuronium ...
In AIP, the porphyrin precursors, porphobilinogen and amino-levulinic acid (ALA), accumulate. The predominant problem appears ...
OXOLINIC ACID. OXOLINIC. 50%. 2 kg. FLUUMICINE. VITAQUIN 500 FLUMEQUINE. 50%. 1 kg. ...
Nalidixic acid NegGam, Wintomylon. Oxolinic acid Uroxin. Piromidic acid Panacid. Pipemidic acid Dolcol. ... whereas pipemic acid (SOSIP=4.6 Delta IF/nmole), cinoxacin (SOSIP=0.5 Delta IF/nmole) and nalidixic acid (SOSIP=0.5 Delta IF/ ... We propose a model for the ternary complex, in which Mg acts as a bridge between the phosphate groups of the nucleic acid and ... She was then referred to an osteopathic physician who treated the patient with intravenous antioxidants and amino acids, an ...
Oxolinic Acid. $75.00 - $215.00. Rated 3.00 out of 5 based on 2 customer ratings ...
67] reported that phosphates considerably hindered oxolinic acid (OXA) and oxytetracycline (OTC) removal while chlorides, ... oxolinic acid and oxytetracycline. Sci. Total Environ. 2013, 463, 274-283. [Google Scholar] [CrossRef] ... Carboxylic acids were also detected at the end of the reaction.. Sousa et al. [84] reported on the TiO2 photocatalytic ... Acetylsalicylic acid (Aspirin). Degussa P25 TiO2 photocatalyst, Xenon lamp irradiation (to simulate solar irradiation) in a ...
Oxolinic acid. 144.. Hymexazol. 194.. Oxpoconazole-fumarate. 145.. Imazalil. 195.. Oxycarboxin. 146.. Imazalil-sulphate. 196.. ...
Oxolinic Acid). 262.1. 244.0*. 40. 17. 6.17. 216.0. 28. 诺氟沙星(NFSX). (Norfloxacin). 320.2. 276.2*. 40. 16. 3.74. ...

No FAQ available that match "oxolinic acid"